These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 2442602

  • 21. Correlation of natural killer cell function with Leu 7 reactivity in patients with humoral immunodeficiency.
    Huwyler T, Morell A, Hirt A, Ricci C, Wagner HP, Barandun S.
    Clin Exp Immunol; 1984 Jun; 56(3):486-92. PubMed ID: 6744658
    [Abstract] [Full Text] [Related]

  • 22. In vitro restoration by interleukin-2 (IL-2) of the impaired natural killer cell activities, IL-2 receptor expression, and T cell proliferation in hemophilia.
    Zaizov R, Cohen IJ, Luria D, Trainin N, Umiel T.
    J Biol Response Mod; 1986 Aug; 5(4):339-50. PubMed ID: 3090209
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy.
    Nicholson JK, McDougal JS, Spira TJ, Cross GD, Jones BM, Reinherz EL.
    J Clin Invest; 1984 Jan; 73(1):191-201. PubMed ID: 6228564
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD, Mitsuyasu R, Gottlieb MS, Lebow LT, Bonavida B.
    J Immunol; 1987 Jul 01; 139(1):55-60. PubMed ID: 3584988
    [Abstract] [Full Text] [Related]

  • 26. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
    Siegel JP, Djeu JY, Stocks NI, Masur H, Gelmann EP, Quinnan GV.
    J Clin Invest; 1985 Jun 01; 75(6):1957-64. PubMed ID: 2989337
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS, Hawkins MJ, Borden EC.
    Cancer Res; 1984 Jul 01; 44(7):3135-9. PubMed ID: 6586292
    [Abstract] [Full Text] [Related]

  • 29. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H, Kakumu S, Fuji A, Ohtani Y, Murase K, Tahara H.
    Clin Exp Immunol; 1987 May 01; 68(2):348-56. PubMed ID: 2820634
    [Abstract] [Full Text] [Related]

  • 30. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb 01; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 31. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
    Gordon M, Bihari B, Goosby E, Gorter R, Greco M, Guralnik M, Mimura T, Rudinicki V, Wong R, Kaneko Y.
    J Med; 1998 Feb 01; 29(5-6):305-30. PubMed ID: 10503166
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
    Pislarasu M, Oproiu A, Taranu D, Herberman RB, Sulica A.
    Cancer Res; 1988 May 01; 48(9):2596-603. PubMed ID: 3356020
    [Abstract] [Full Text] [Related]

  • 34. [Chronic fatigue syndrome--cases in the Kanebo Memorial Hospital].
    Ogawa R, Toyama S, Matsumoto H.
    Nihon Rinsho; 1992 Nov 01; 50(11):2648-52. PubMed ID: 1337561
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of natural killer cell activity in patients with persistent generalized lymphadenopathy and acquired immunodeficiency syndrome.
    Creemers PC, Stark DF, Boyko WJ.
    Clin Immunol Immunopathol; 1985 Aug 01; 36(2):141-50. PubMed ID: 3874030
    [Abstract] [Full Text] [Related]

  • 36. Acting mechanisms of Lentinan in human--II. Enhancement of non-specific cell-mediated cytotoxicity as an interferon inducer.
    Miyakoshi H, Aoki T, Mizukoshi M.
    Int J Immunopharmacol; 1984 Aug 01; 6(4):373-9. PubMed ID: 6207124
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A novel case of Hyper IgE syndrome combined with natural killer cell deficiency.
    Zhang X, Liu Y, Liu Y, Dai H.
    Chin Med J (Engl); 2014 Aug 01; 127(5):982-3. PubMed ID: 24571902
    [No Abstract] [Full Text] [Related]

  • 39. Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome.
    Baraniuk JN, Eaton-Fitch N, Marshall-Gradisnik S.
    Front Immunol; 2024 Aug 01; 15():1440643. PubMed ID: 39483457
    [Abstract] [Full Text] [Related]

  • 40. Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements.
    Malnati MS, Lusso P, Ciccone E, Moretta A, Moretta L, Long EO.
    J Exp Med; 1993 Sep 01; 178(3):961-9. PubMed ID: 8394407
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.